Ranitidine in long-term duodenal ulcer treatment: A multicentre trial

F. Di Mario, O. Albano, G. Angelini, G. Cavallini, F. Doronzo, R. Farini, A. Francavilla, R. Naccarato, L. A. Scuro, F. Vianello

Research output: Contribution to journalArticlepeer-review


An endoscopically controlled clinical trial on maintenance Ranitidine treatment of scarred duodenal ulcer was carried out in 78 patients, randomly allocated to either 150 mg Ranitidine at night or low-dose antacid when necessary in a 1-year follow-up study. The maintenance Ranitidine regime prevented ulcer relapse in 23 of 31 cases (74.2%), without any significant adverse reaction. In the control group, the relapse was prevented in 12 of 30 cases (40%); the difference was found to be statistically significant.

Original languageEnglish
Pages (from-to)260-263
Number of pages4
Issue number4
Publication statusPublished - 1982

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Ranitidine in long-term duodenal ulcer treatment: A multicentre trial'. Together they form a unique fingerprint.

Cite this